Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Eddy S. Konaniah"'
Autor:
Caíque S. M. Fonseca, Joshua E. Basford, David G. Kuhel, Eddy S. Konaniah, James G. Cash, Vera L. M. Lima, David Y. Hui
Publikováno v:
Molecules, Vol 25, Iss 19, p 4369 (2020)
Overfeeding of a hypercaloric diet leads to obesity, diabetes, chronic inflammation, and fatty liver disease. Although limiting fat or carbohydrate intake is the cornerstone for obesity management, whether lowering fat or reducing carbohydrate intake
Externí odkaz:
https://doaj.org/article/ae93cb2345a342d5a1e39c2639d9cf96
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 4 (2017)
BackgroundNumerous epidemiological studies support an inverse association between serum bilirubin levels and the incidence of cardiovascular disease; however, the mechanism(s) by which bilirubin may protect against atherosclerosis is undefined. The g
Externí odkaz:
https://doaj.org/article/2749c526c1234f258b5fc4ff6de618b1
Autor:
Zhenyu Qin, Eddy S. Konaniah, Bonnie Neltner, Raphael A. Nemenoff, David Y. Hui, Neal L. Weintraub
Publikováno v:
Journal of Lipid Research, Vol 51, Iss 6, Pp 1471-1477 (2010)
ATP7A primarily functions to egress copper from cells, thereby supplying this cofactor to secreted copper-accepting enzymes. This ATPase has attracted significant attention since the discovery of its mutation leading to human Menkes disease and the d
Externí odkaz:
https://doaj.org/article/6512e88fb05f4c95af1c1e320ce7563c
Publikováno v:
Arterioscler Thromb Vasc Biol
Objective: Genome-wide studies showed that mutation in apoER2 (apolipoprotein E receptor-2) is additive with ε4 polymorphism in the APOE gene on cardiovascular disease risk in humans. ApoE or apoER2 deficiency also accelerates atherosclerosis lesion
Autor:
Narasimha Hegde, David G. Kuhel, Miki Watanabe, David Y. Hui, Lindsey E. Romick-Rosendale, James G. Cash, Eddy S. Konaniah
Publikováno v:
Molecular Metabolism, Vol 16, Iss, Pp 55-64 (2018)
Objective: Obesity and obesity-related metabolic disorders are major health problems worldwide. The most effective obesity intervention is bariatric surgery. This study tested the hypothesis that bariatric surgery alters phospholipid metabolism in th
Autor:
Anissa Moussa, Moises A. Huaman, Stephanie Schmidt, Eddy S. Konaniah, George S. Deepe, Ravi K. Komaravolu, Joseph E. Qualls, David Y. Hui, Carl J. Fichtenbaum, David G. Kuhel, Shinsmon Jose
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Frontiers in Immunology
Frontiers in Immunology
Tuberculosis has been associated with increased risk of atherosclerotic cardiovascular disease. To examine whether mycobacterial infection exacerbates atherosclerosis development in experimental conditions, we infected low-density lipoprotein recepto
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 37:1046-1049
Objective— Mice with adipocyte-specific inactivation of low-density lipoprotein receptor–related protein-1 (LRP1) are resistant to diet-induced obesity and hyperglycemia because of compensatory thermogenic response by muscle. However, the physiol
Autor:
David Y. Hui, Vera Lúcia de Menezes Lima, David G. Kuhel, Caíque Silveira Martins da Fonseca, Joshua E. Basford, Eddy S. Konaniah, James G. Cash
Publikováno v:
Molecules
Molecules, Vol 25, Iss 4369, p 4369 (2020)
Molecules, Vol 25, Iss 4369, p 4369 (2020)
Overfeeding of a hypercaloric diet leads to obesity, diabetes, chronic inflammation, and fatty liver disease. Although limiting fat or carbohydrate intake is the cornerstone for obesity management, whether lowering fat or reducing carbohydrate intake
Autor:
Sheryl E. Koch, Anja Jaeschke, David Y. Hui, Nathan Robbins, Eddy S. Konaniah, Jack Rubinstein
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 38
Introduction: Apolipoprotein E receptor 2 (ApoER2) is highly expressed in brain and testes, but also in macrophages, endothelial and vascular smooth muscle cells, as well as heart. Importantly, genome-wide association studies have linked polymorphism
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Numerous epidemiological studies support an inverse association between serum bilirubin levels and the incidence of cardiovascular disease; however, the mechanism(s) by which bilirubin may protect against atherosclerosis is undefined. The